Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MSLuisa María Villar, José C. Álvarez‐Cermeño, Mercedes Espiño et al.|Journal of Clinical Investigation|2005Cited by 257
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MSJosé Ignacio Fernández-Velasco, Luisa María Villar, Jens Kühle et al.|Neurology Neuroimmunology & Neuroinflammation|2021Cited by 65
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy DrugsEnric Monreal, Luisa María Villar, José Ignacio Fernández-Velasco et al.|JAMA Neurology|2023Cited by 51
Serum biomarkers at disease onset for personalized therapy in multiple sclerosisEnric Monreal, Luisa María Villar, José Ignacio Fernández-Velasco et al.|Brain|2024Cited by 44
Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated SyndromeEnric Monreal, Luisa María Villar, Lucienne Costa‐Frossard et al.|Neurology Neuroimmunology & Neuroinflammation|2021Cited by 40